Combination Chemotherapy in Treating Children With Refractory or Relapsed Hodgkin's Lymphoma

DISEASE CHARACTERISTICS: * Histologically confirmed refractory or relapsed Hodgkin's lymphoma * Mixed cellularity, not otherwise specified (NOS) * Lymphocytic depletion, NOS * Lymphocytic depletion, diffuse fibrosis * Lymphocytic depletion, reticular * Lymphocytic predominance, NOS * Lymphocytic predominance, diffuse * Lymphocytic predominance, nodular * Hodgkin's paragranuloma NOS * Hodgkin's granuloma * Hodgkin's sarcoma * Nodular sclerosis, NOS * Nodular sclerosis, cellular phase * Nodular sclerosis, lymphocytic predominance * Nodular sclerosis, mixed cellularity * Nodular sclerosis, lymphocytic depletion * Other (type not specified) * In first relapse * Metastasis to bone marrow with granulocytopenia, anemia, and/or thrombocytopenia allowed * Not enrolled on POG-9426 unless there is an extranodal site of recurrence PATIENT CHARACTERISTICS: Age: * Under 30 at diagnosis Performance status: * Lansky 60-100% (for patients 16 years and under) * Karnofsky 60-100% (for patients over 16 years) Life expectancy: * At least 2 months Hematopoietic: * See Disease Characteristics * Absolute neutrophil count at least 1,000/mm\^3 * Platelet count at least 75,000/mm\^3 (transfusion independent) Hepatic: * Bilirubin no greater than 1.5 times normal * SGOT or SGPT less than 2.5 times normal Renal: * Creatinine no greater than 1.5 times normal * Creatinine clearance or radioisotope glomerular filtration rate at least 70 mL/min Cardiovascular: …